Building a team to address the unmet medical need associated with food allergies

Since our founding in 2011, we have built a team of disciplined and experienced biotech and pharmaceutical professionals who relish the challenges of drug development and commercialization and strive to bring critical healthcare solutions to patients

 

Everyone at Aimmune is dedicated to addressing the urgent unmet need for treatments for food allergies, through our individual functions — be they scientific, medical, development, commercial, technical or operational — and our collaborative efforts. We take inspiration from the patients, families and physicians managing the life-threatening risks associated with food allergies. Every day, we work hard toward the goal of offering them a margin of safety that can help alleviate the fear and stress of accidental exposure to food allergens.

If you are interested in helping define an emerging therapeutic space and working to make a profound difference in the lives of people with food allergies, please contact careers@aimmune.com and follow our postings of current career opportunities.

Current listings — United States

Clinical Development – Vice President

Clinical Operations – Senior Clinical Project Manager

CoreRX – Analytical Development & Quality Control Professional

CoreRX – Process Engineer

CoreRX – Project Manager

Manufacturing and Process Development – Florida Site Manager

QA Document Control Specialist — Manager

SEC Reporting & SOX Compliance — Senior Manager

Statistical Programming — Senior Biostatistics Manager

Current listings — London, UK

Biometrics — Director

Clinical Operations — Associate Director

Clinical Operations — Associate Director (Contracts Management)

Clinical Development — Vice President

Clinical Project Manager — Manager

Clinical Science — Associate Director/Director

Regulatory Affairs (EU) — Senior Manager

Aimmune is committed to providing a positive work environment that supports rigorous execution, innovative solutions and equal opportunity.